It is noteworthy that, the effect of chemosensitivity changing with ANXA2 knockdown seems weaker in vivo: not only minor decrease of tumor volume in knockdown group compared with control group, but also no significance difference with pro-apoptotic factors as AIF and cleaved-PARP. This evidence concerns the gene ANXA2 and neoplasm.